openPR Logo
Press release

More Determined Through A Series Of Mergers And Acquisitions By Us Pharmacy Benefit Management (PBM) Industry 2016 Edition

12-14-2016 04:34 PM CET | Health & Medicine

Press release from: Pharmacy Benefit Management

"US Pharmacy Benefit Management (PBM) Industry Report: 2016 Edition" The Report covers current Market Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect.

Description-

In the US, Pharmacy Benefit Management (PBM) deals with the management of prescription drug programs. It acts as an intermediary between health plans, drug companies, retail pharmacies and patients. Initially, PBMs used to process pharmaceutical claims for health plans. But nowadays in addition to this, PBMs have created more significant ‘pharmacy benefit’ by providing a system for reimbursement of drug claims, processing and cost control. The US prescription volume and pharmaceutical sales has witnessed an exceptional growth over the past few years and the same pattern is likely to continue in the near future. Therefore, through rebates from pharmaceutical manufacturers, price discounts from retails, and effective mail service pharmacies, the PBMs emphasis on enabling the plan sponsors and individuals to obtain prescribed drugs at lower prices.

Get Sample Report With TOC @ https://goo.gl/1ltEOf

The PBM providers control drug spending and utilization by virtue of their advanced tools and techniques, encouraging use of generics and other lower-cost medications. In the US, there are some independent PBM’s while some are owned by managed care organizations and retail pharmacies. Today, the PBM industry has become more determined through a series of mergers and acquisitions.

Some of the factors driving the growth of the PBM industry are: accelerating US aging population, increasing life expectancy rate and incidences of chronic and infectious diseases which further increase the healthcare expenditure and pharmaceutical sales in the US. The ongoing trends and development in the PBM industry include rising medicare enrollments and increased acceptance of specialty drugs.

This report assesses the US PBM industry in terms of both market volume and market value. The increasing competition in the PBM industry has been analyzed on number of factors: revenue, dispensing specialty pharmaceuticals, claims and PDP lives. The top three companies having a vicious competition with each other and dominating the PBM industry are- Express Script, CVS Health and Catamaran. These players are being profiled in the report along with their key financials and strategies for growth.

1. Overview
1.1 Introduction
1.2 History of PBM
1.3 Retail Dispensing Process & Flow of Funds
1.4 Mail Dispensing Process and Flow of Funds

2. The US PBM Market
2.1 Rx Market
Market Volume
Growth Rate
Market Segments
Branded Vs Generic Growth
Dispensing Channels
2.2 Pharmaceutical Sales
Sales Growth
Branded Vs Generic Market
Dispensing Channels
2.3 Specialty Drugs

3. Market Dynamics
3.1 Growth Drivers
3.1.1 Increasing Life Expectancy Rate in the US
3.1.2 Rising Healthcare Expenditure in the US
3.1.3 Rising Pharmaceutical Sales
3.1.4 Accelerating US Aging Population
3.1.5 Ameliorating Economic Conditions
3.1.6 Rising Incidences of Chronic and Infectious Diseases
3.1.7 Rising Medicare Enrollments

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Researchmoz Global Pvt. Ltd.
90 State Street,
Albany, NY 12207,
United States,
Tel: 866-997-4948 (Us-Canada Toll Free),
Tel: +1-518-621-2074

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release More Determined Through A Series Of Mergers And Acquisitions By Us Pharmacy Benefit Management (PBM) Industry 2016 Edition here

News-ID: 395963 • Views: 478

More Releases from Pharmacy Benefit Management

US Pharmacy Benefit Management (PBM) Industry Key Trends, Size, Growth, Shares A …
Researchmoz added Most up-to-date research on "US Pharmacy Benefit Management (PBM) Industry Report: 2014 Edition" to its huge collection of research reports. In the US, Pharmacy Benefit Management (PBM) deals with the management of prescription drug programs. It acts as an intermediary between health plans, drug companies, retail pharmacies and patients. Initially, PBMs used to process pharmaceutical claims for health plans. But nowadays in addition to this, PBMs have created more
US Pharmacy Benefit Management (PBM) Industry Report: 2015 Edition | Now Availab …
Researchmoz added Most up-to-date research on "US Pharmacy Benefit Management (PBM) Industry Report: 2015 Edition" to its huge collection of research reports. PBMs initially enacted the role of a third-party administrator, administering the drug claims of health plans/employers. However, they widened the horizon by expanding into a wide variety of business functions, eventually resulting in better management of drug benefits for members and reducing the overall drug spending costs for plan
US Pharmacy Benefit Management (PBM) Industry Key Trends, Size, Growth, Shares A …
Researchmoz added Most up-to-date research on "The US Pharmacy Benefit Management (PBM) Market: Industry Analysis & Outlook (2016-2020)" to its huge collection of research reports. A pharmacy benefit manager (PBM) is a third-party administrator (TPA) of prescription drug programs for commercial health plans, self-insured employer plans, and federal employee’s health benefits program in the US. Pharmacy benefit managers act as an intermediary between the payer and everyone else in the healthcare
US Pharmacy Benefit Management (PBM) Industry Analysis, Demand, Trend, Growth & …
Researchmoz added Most up-to-date research on "The US Pharmacy Benefit Management (PBM) Market: Industry Analysis & Outlook (2016-2020)" to its huge collection of research reports. A pharmacy benefit manager (PBM) is a third-party administrator (TPA) of prescription drug programs for commercial health plans, self-insured employer plans, and federal employee’s health benefits program in the US. Pharmacy benefit managers act as an intermediary between the payer and everyone else in the healthcare

All 5 Releases


More Releases for PBM

U.S. Pharmacy Benefit Management (PBM) Market Outlook To 2026
U.S. Pharmacy Benefit Management (PBM) Market Outlook To 2026: In-Depth Market Overview, Key Business Model (Standalone, Health Insurance Providers, Retail Pharmacy), End-Use Type (Commercial, Federal), Regional Segmentation, Pricing Analysis, Pipeline Analysis, Competitive Dynamics, M&A Insights, Segment Forecast And Conclusion The U.S. Pharmacy Benefit Management (PBM) Market was valued at $370.00Billion in 2018 and is forecast to grow at a modest10.02 % CAGR between2018 and 2025, culminating in 2026 global sales of
Global Pharmacy Benefit Management (PBM) Market
https://www.qandqmarketresearch.com/report-sample/pharmacy-benefit-management-pbm2018-market-62 Global Pharmacy Benefit Management (PBM) Market https://www.qandqmarketresearch.com/report-sample/pharmacy-benefit-management-pbm2018-market-62 The Global and Chinese Pharmacy Benefit Management PBM Industry, 20132023 Market Research Report is a professional and indepth study on the current state of the global Pharmacy Benefit Management PBM industry with a focus on the Chinese market. The report provides key statistics on the market status of the Pharmacy Benefit Management PBM manufacturers and is a valuable source of guidance and direction for companies
Pharmacy Benefit Manager (PBM) Market -Prophesy On Healthcare Infrastructure 202 …
Global Pharmacy Benefit Manager Market: Overview The healthcare industry has always been on an upswing but in the recent times, owing to the increased income of urban populations in emerging economies, the demand for proper management of healthcare infrastructure has multiplied exponentially. Pharmaceutical and diagnostic device manufacturers, as well as government agencies, are now leveraging the concept of pharmacy benefit managers (PBMs), who essentially are third-party administrators of prescribed drug distribution
Global Pharmacy Benefit Management (PBM) Market Technology Trends in Future
The Latest Research Report Global Pharmacy Benefit Management (PBM) Market Size,Status and Forecast 2025 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz The main objective of this report is to aid the user in understanding the market as a whole, its definitions, segmentation, market potential, influential trends, and the barriers that it is facing. Meticulous research and analysis were an important part
Pharmacy Benefit Management (PBM) Market: Moving Towards a Brighter Future
Qyresearchreports include new market research report Pharmacy Benefit Management (PBM) to its huge collection of research reports. The business landscape of the global Pharmacy Benefit Management (PBM) market is undergoing dynamic changes. In order to facilitate a complete understanding of the complex industry scenario for clients and thus enhance their decision making process, the study on the global market presents a methodological explanation of this dynamic market scenario. The research study
Global Pharmacy Benefit Management (PBM) Market Report 2016 - 2024
Pharmacy Benefit Management Pharmaceutical drug prices continue soaring up and contribute significantly to total healthcare expenditure worldwide. The cost of drugs has risen more than any of the healthcare expenditure. As per the insurance consultants at Milliman, drug costs were merely 16% of the overall health costs in 2015, which rose by 102% over a decade and accounted for around 14% in 2015. Rising drug prices and increasing consumer spending on